Cargando…

Cold stimulation test in patients with plaque psoriasis

Detalles Bibliográficos
Autores principales:	Aleksiev, Teodor, Ivanova, Zlatina, Dobrev, Hristo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512202/ https://www.ncbi.nlm.nih.gov/pubmed/37881047 http://dx.doi.org/10.1111/srt.13421

Ejemplares similares

Use of a novel Indentometer to evaluate skin induration in localized scleroderma and psoriasis vulgaris
por: Ivanova, Zlatina, et al.
Publicado: (2022)

Onychomadesis in a COVID-19 patient
por: Ivanova, Zlatina Georgieva, et al.
Publicado: (2022)

Use of a novel indentometer to evaluate skin stiffness in healthy and diseased human skin
por: Ivanova, Zlatina, et al.
Publicado: (2023)

Risk of respiratory infection in patients with plaque psoriasis
por: Svedbom, Axel, et al.
Publicado: (2021)

Risankizumab for Plaque and Guttate Psoriasis in a Patient with IgA-Related Glomerulonephritis
por: Dattola, Annunziata, et al.
Publicado: (2021)

Widespread Superficial Dermatophytosis in Patient on Secukinumab for Treatment of Chronic Plaque Psoriasis
por: Neema, Shekhar, et al.
Publicado: (2019)

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study
por: Lytvyn, Yuliya, et al.
Publicado: (2021)

Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab
por: Palmisano, Gerardo, et al.
Publicado: (2023)

Exacerbation of generalized plaque psoriasis after tuberculin test
por: Corrà, Alberto, et al.
Publicado: (2021)

Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
por: Cao, Zhiqiang, et al.
Publicado: (2022)

Guselkumab for plaque psoriasis
Publicado: (2019)

Bimekizumab for plaque psoriasis
Publicado: (2022)

Stigmatization among Patients with Plaque Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2023)

Myocardial Infarction in a Patient Treated with Anti-Interleukin-12 Biological Agent for Chronic Plaque Psoriasis
por: Stinco, Giuseppe, et al.
Publicado: (2014)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

Evaluation of pancreatic function in patients with plaque psoriasis
por: Białecka, Agnieszka
Publicado: (2023)

Efficacy of Methotrexate in patients with plaque type psoriasis
por: Haider, Sabiqa, et al.
Publicado: (2014)

Prolidase activity in chronic plaque psoriasis patients
por: Sürücü, Hacer Altın, et al.
Publicado: (2015)

The content validity of the PSS in patients with plaque psoriasis
por: Rentz, A. M., et al.
Publicado: (2017)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
por: Gambardella, Alessio
Publicado: (2019)

Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model
por: Kvist, Peter H, et al.
Publicado: (2009)

Cytotoxic and Antibacterial Prenylated Acylphloroglucinols from Hypericum olympicum L.
por: Ilieva, Yana, et al.
Publicado: (2023)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Bacterial colonization of psoriasis plaques. Is it relevant?
por: Marcus, Eva, et al.
Publicado: (2011)

Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
por: Huang, He, et al.
Publicado: (2023)

Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
por: Bellinato, Francesco, et al.
Publicado: (2023)

Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab
por: Morita, Akimichi, et al.
Publicado: (2020)

Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
por: Ikuma, Daiuske, et al.
Publicado: (2019)

Stigma Experienced by the Caregivers of Patients with Chronic Plaque Psoriasis
por: Grover, Sandeep, et al.
Publicado: (2021)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
por: Ambrogio, Francesca, et al.
Publicado: (2022)

Difference in health‐related quality of life between anxiety and depressive symptoms in Japanese patients with plaque psoriasis: the ProLOGUE study
por: Ohata, C., et al.
Publicado: (2021)

Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
por: Pettitt, Dan, et al.
Publicado: (2022)

Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study
por: Menter, M.A., et al.
Publicado: (2020)

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis
por: Khatri, Amit, et al.
Publicado: (2019)

Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488)
por: Mahé, E., et al.
Publicado: (2022)

Multiple keratoacanthomas developing in healing plaques of Psoriasis
por: Relhan, Vineet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nr6egst71el8tm4g3bf3n57cec